CAVALETTI, GUIDO ANGELO
 Distribuzione geografica
Continente #
NA - Nord America 80.411
AS - Asia 49.057
EU - Europa 35.706
SA - Sud America 5.979
Continente sconosciuto - Info sul continente non disponibili 4.221
AF - Africa 1.015
OC - Oceania 202
AN - Antartide 1
Totale 176.592
Nazione #
US - Stati Uniti d'America 75.841
SG - Singapore 16.141
CN - Cina 9.672
VN - Vietnam 9.528
IT - Italia 9.177
HK - Hong Kong 6.053
RU - Federazione Russa 5.128
DE - Germania 4.649
BR - Brasile 4.540
CA - Canada 3.884
SE - Svezia 3.549
IE - Irlanda 3.184
UA - Ucraina 2.616
GB - Regno Unito 1.882
FR - Francia 1.502
IN - India 1.387
BD - Bangladesh 1.137
KR - Corea 1.011
FI - Finlandia 970
ID - Indonesia 629
AT - Austria 611
TR - Turchia 554
AR - Argentina 541
JP - Giappone 489
NL - Olanda 488
IQ - Iraq 454
ES - Italia 356
MX - Messico 355
ZA - Sudafrica 320
PK - Pakistan 310
DK - Danimarca 283
PL - Polonia 273
LT - Lituania 244
SA - Arabia Saudita 219
PH - Filippine 208
EC - Ecuador 206
BE - Belgio 174
CH - Svizzera 172
AU - Australia 167
CO - Colombia 167
VE - Venezuela 156
MY - Malesia 146
UZ - Uzbekistan 143
EG - Egitto 132
MA - Marocco 116
CL - Cile 105
IR - Iran 103
TW - Taiwan 103
PY - Paraguay 94
TN - Tunisia 89
JO - Giordania 87
KE - Kenya 82
AE - Emirati Arabi Uniti 78
ET - Etiopia 71
PE - Perù 70
KZ - Kazakistan 68
IL - Israele 67
NP - Nepal 67
TH - Thailandia 61
JM - Giamaica 59
AZ - Azerbaigian 56
CR - Costa Rica 55
CZ - Repubblica Ceca 55
EU - Europa 54
RO - Romania 52
OM - Oman 50
UY - Uruguay 50
DZ - Algeria 48
PT - Portogallo 48
GR - Grecia 41
BO - Bolivia 40
AL - Albania 39
HN - Honduras 38
DO - Repubblica Dominicana 32
KG - Kirghizistan 31
LB - Libano 30
PS - Palestinian Territory 30
PA - Panama 29
BG - Bulgaria 28
NZ - Nuova Zelanda 27
GT - Guatemala 26
HR - Croazia 25
RS - Serbia 25
BH - Bahrain 22
NI - Nicaragua 22
AO - Angola 21
NO - Norvegia 21
TT - Trinidad e Tobago 21
HU - Ungheria 19
LY - Libia 19
MD - Moldavia 18
GE - Georgia 17
CI - Costa d'Avorio 16
NG - Nigeria 16
SY - Repubblica araba siriana 16
KW - Kuwait 15
SN - Senegal 15
QA - Qatar 13
SV - El Salvador 13
LV - Lettonia 12
Totale 172.173
Città #
Ann Arbor 9.456
Singapore 9.390
Ashburn 6.234
Hong Kong 5.884
Woodbridge 4.646
Dallas 4.581
San Jose 4.215
Houston 3.573
Fairfield 3.563
Dublin 3.085
Milan 3.045
Ho Chi Minh City 2.902
Chandler 2.819
Toronto 2.779
Jacksonville 2.572
Frankfurt am Main 2.547
Wilmington 2.300
Hanoi 2.279
New York 1.873
Dearborn 1.768
Santa Clara 1.590
Seattle 1.473
Beijing 1.353
Los Angeles 1.305
Princeton 1.261
Chicago 1.215
Cambridge 1.190
The Dalles 1.046
Hefei 966
Boardman 836
Council Bluffs 820
Seoul 763
Nanjing 734
Rome 682
Lauterbourg 637
Shanghai 569
Buffalo 510
Vienna 493
Hangzhou 471
Lawrence 466
Moscow 458
Altamura 450
São Paulo 420
Jakarta 417
Lachine 415
Helsinki 385
Guangzhou 334
Orem 292
Da Nang 290
Haiphong 287
Tokyo 273
Dong Ket 256
Munich 250
Columbus 240
Nanchang 224
San Diego 217
London 212
Shenyang 210
Atlanta 209
Andover 206
Brooklyn 200
Baghdad 197
Vilnius 197
Chennai 185
Biên Hòa 183
Montreal 179
Phoenix 179
Denver 177
Warsaw 173
Ha Long 172
Hải Dương 170
Changsha 168
Rio de Janeiro 168
Nuremberg 165
San Francisco 159
Hebei 154
Tianjin 154
Turin 148
Johannesburg 142
Falls Church 136
Jinan 130
Ottawa 128
Tashkent 128
Quận Bình Thạnh 125
Boston 121
Manchester 121
Stockholm 121
Fremont 120
Jiaxing 120
Brussels 119
Can Tho 118
Pune 118
Dhaka 115
Zurich 115
Thái Nguyên 114
Grafing 112
Kazan 112
Ninh Bình 111
Amsterdam 110
Naples 106
Totale 109.706
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.139
Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update 1.012
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 765
La citofluorimetria a flusso nella caratterizzazione immunofenotipica dei linfociti in corso di Encefalite Autoimmune Sperimentale. 707
Nelarabine-Induced Neurotoxicity: Reversible Damage not only on Peripheral Nerves 690
Paclitaxel acutely activates ICRAC in sensory neurons: implications for paclitaxel-induced peripheral neuropathy 646
CIPN and its mechanism of development 643
High-Resolution MRI for Peripheral Nervous System Imaging: Volumetric Rendering in Rodent Models 631
ApoE-modified solid lipid nanoparticles: A feasible strategy to cross the blood-brain barrier 614
Paclitaxel alters the microvascular network in the central and peripheral nervous system of rats with chemotherapy-induced painful peripheral neuropathy 586
Comparing the different response of PNS and CNS injured neurons to mesenchymal stem cell treatment 560
CHARACTERIZATION OF AXONAL DEGENERATION MECHANISMS IN BORTEZOMIB-TREATED SENSORY NEURONS 557
Morphofunctional characterisation of axonal damage in different rat models of chemotherapy-induced peripheral neurotoxicity: the role of nerve excitability testing 513
SOMETHING NEW ABOUT BORTEZOMIB NEUROTOXICITY 511
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 506
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 500
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 498
Design and Synthesis of Chitosan—Gelatin Hybrid Hydrogels for 3D Printable in vitro Models 498
INSIGHT ON BORTEZOMIB INDUCED MICROTUBULES STABILITY AND MITOCHONDRIAL TRAFFICKING 496
ETNK1 mutations promote ROS production and DNA damage through increased mitochondrial activity 490
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 469
Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy 461
Protective Effect of Human Mesenchymal Stem Cells on the Survival of Pancreatic Islets 457
Effect of age on metabolomic changes in a model of paclitaxel‐induced peripheral neurotoxicity 457
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 456
Angiogenesis-Related New Mechanisms for Chemotherapy-Induced Painful Peripheral Neuropathy in the Rat 455
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 454
Malattie del Sistema Nervoso 450
Antitumoral Effect of Hibiscus sabdariffa on Human Squamous Cell Carcinoma and Multiple Myeloma Cells 448
Evaluation of the Profile and Mechanism of Neurotoxicity of Water-Soluble [Cu(P)4]PF6 and [Au(P)4]PF6 (P = thp or PTA) Anticancer Complexes 448
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 445
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 444
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 441
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 436
Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients 435
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 435
Loss of CDKN2B expression as a potential marker of resistance to CDK4/6 inhibitor in Luminal Breast Cancer cells 434
Oxaliplatin-induced peripheral neurotoxicity: molecular insights 431
Sensitivity and specificity of a commercial ELISA test for anti-MAG antibodies in patients with neuropathy 430
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up 429
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 428
Age-related changes in the function and structure of the peripheral sensory pathway in mice 425
Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings 425
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 424
ETNK1 MUTATIONS INCREASE MITOCHONDRIAL ACTIVITY AND PROMOTE DNA DAMAGE THROUGH ROS PRODUCTION 423
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 417
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 417
Toxic Medications in Charcot-Marie-Tooth Patients: A Systematic Review 412
Anti-multiple myeloma potential of secondary metabolites from hibiscus sabdariffa 412
Enhanced brain targeting of engineered solid lipid nanoparticles 410
Current use of fluid biomarkers as outcome measures in Multiple Sclerosis (MS): a review of ongoing pharmacological clinical trials 408
Malattie del Sistema Nervoso 406
Tubulin polymerization and mitochondria transport involvement in Bortezomib peripheral neurotoxicity. 406
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 406
Effect of age on metabolomic changes in a model of paclitaxel-induced neurotoxicity 406
Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20) 402
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 399
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 398
A role for hemopexin in oligodendrocyte differentiation and myelin formation 397
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 389
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 388
Microtubule stabilisation and mitochondrial dysfunctions as axonal degeneration mechanisms in bortezomib-treated sensory neurons 386
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics 384
3D Digital tools in human anatomy teaching from peer-to-peer tutoring to clinically oriented approaches: a single center experience. 381
Pathogenic role of delta 2 tubulin in bortezomib-induced peripheral neuropathy 375
ITF6475, a New Histone Deacetylase 6 Inhibitor, Prevents Painful Neuropathy Induced by Paclitaxel 373
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 371
CENTRAL AND PERIPHERAL MICROVASCULAR NETWORK IS ABNORMAL IN RATS WITH PAINFUL-CHEMOTHERAPY INDUCED NEUROPATHY: NEW PATHOPHYSIOLOGICAL MECHANISMS OVER THE HORIZON? 367
Morphological and morphometric analysis of paclitaxel and docetaxel-induced peripheral neuropathy in rats 367
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 360
Tubulin binding potentially clears up Bortezomib and Carfilzomib differential neurotoxic effect 358
TWIST1 Upregulation Is a Potential Target for Reversing Resistance to the CDK4/6 Inhibitor in Metastatic Luminal Breast Cancer Cells 357
A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer 355
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 350
The Italian multiple sclerosis register 350
Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy 350
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 346
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 346
Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients 346
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS) 345
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 344
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 344
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 343
Translation of paclitaxel-induced peripheral neurotoxicity from mice to patients: the importance of model selection 337
Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation 336
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 333
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents 333
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 330
Dorsal Root Ganglia Neurons Morphometry Analysing Method Optimization 329
Role of MAPKs in platinum-induced neuronal apoptosis 329
Proteasome inhibitors-based chemotherapy induced neurotoxicity: focus on cytoskeleton and mitochondrial dysfunction 328
Functional Magnetic Resonance Imaging of Rats with Experimental Autoimmune Encephalomyelitis Reveals Brain Cortex Remodeling 328
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 328
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings 327
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 327
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis 326
Sodium-Calcium Exchanger 2: A Pivotal Role in Oxaliplatin Induced Peripheral Neurotoxicity and Axonal Damage? 323
Identification of dual Sigma1 receptor modulators/acetylcholinesterase inhibitors with antioxidant and neurotrophic properties, as neuroprotective agents 323
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 322
An in vitro model of dorsal root ganglion (DRG) neurons to investigate the molecular mechanisms of oxaliplatin-induced peripheral neuropathy. 322
Totale 43.554
Categoria #
all - tutte 551.573
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 551.573


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.821 0 761 732 674 494 679 356 401 350 500 563 1.311
2022/202312.587 1.556 3.514 1.176 1.070 883 1.959 170 655 891 141 313 259
2023/202410.535 333 388 446 421 1.434 2.356 1.952 439 784 247 246 1.489
2024/202525.396 1.580 2.865 1.747 1.196 2.151 927 1.382 972 2.935 3.296 2.230 4.115
2025/202670.090 9.620 5.692 7.286 5.626 6.128 3.522 8.829 3.162 5.066 5.392 4.902 4.865
2026/20274.601 3.632 969 0 0 0 0 0 0 0 0 0 0
Totale 176.592